Effect of Biannual Azithromycin Distribution to Infants on Community Gut Resistome and Microbiome: A Cluster-Randomized, Controlled Trial
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.25-0238 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Boubacar Coulibaly und 25 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso. Hauptthemen laut MEDLINE: Azithromycin, Anti-Bacterial Agents, Gastrointestinal Microbiome, Drug Resistance, Bacterial. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation.
Abstract (Originalsprache)
Biannual azithromycin administration to preschool children in sub-Saharan Africa improved childhood mortality but selected for antibiotic resistance (AMR). WHO guidelines recommended focusing treatment on infants ages 1–11 months old to reduce mortality while minimizing selection of AMR. The Infant Mortality Reduction by the Mass Administration of Azithromycin study was a double-masked, placebo-controlled, cluster-randomized trial that investigated these WHO guidelines. Health centers from three regions of Burkina Faso were randomized in a 2:1 ratio to receive either biannual azithromycin (67%) or placebo (33%) distribution to children 1–11 months old. A total of 3,524 rectal samples from children ages 1–59 months old from 60 randomly selected communities were included in the analysis. The prespecified primary outcome was the community-level fold change in macrolide resistance determinants between arms at the 24-month time point. Macrolide resistance determinants in the gut of children in communities whose infants received azithromycin did not increase compared with those in communities treated with placebo (1.05-fold change). Similarly, the fold changes for resistance determinants for beta-lactams, metronidazole, sulfonamides, tetracycline, and trimethoprim were 0.99-fold, 1.00-fold, 1.22-fold, 0.96-fold, and 0.96-fold, respectively. At 6 months after the fourth treatment, there were no detectable differences in the microbiome structure (Euclidean permutational multivariate analysis of variance) and Shannon diversity index between treatment arms. These results suggest that biannual azithromycin administration to children 1–11 months old did not lead to a significant long-lasting increase in gut AMR or alterations of the gut microbiomes of children 1–59 months old in the community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
- Francis I. Proctor Foundation, University of California, San Francisco, California.
- Helen Keller International, Dakar, Senegal.
- Helen Keller International, Ouagadougou, Burkina Faso.
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California.
- Department of Ophthalmology, University of California, San Francisco, California.
Förderung
- Gates Foundation
Zitieren
APA
Coulibaly, B., Yan, D., Sié, A., Dramane, K., Bountogo, M., Clarisse, D., Lucienne, O., Yago-Wienne, F., Touré, D., Dimithé, G., Khassanov, R., Sidibé, S., Somé, N. P., Zhong, L., Chen, C., Yu, D., Liu, Y., Abraham, T., Peterson, B., …, & Doan, T. (2025). Effect of Biannual Azithromycin Distribution to Infants on Community Gut Resistome and Microbiome: A Cluster-Randomized, Controlled Trial. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0238
Vancouver
Coulibaly B, Yan D, Sié A, Dramane K, Bountogo M, Clarisse D, et al. Effect of Biannual Azithromycin Distribution to Infants on Community Gut Resistome and Microbiome: A Cluster-Randomized, Controlled Trial. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.25-0238
BibTeX
@article{Coulibaly2025,
author = {Coulibaly, Boubacar and Yan, Daisy and Sié, Ali and Dramane, Kiemdé and Bountogo, Mamadou and Clarisse, Dah and Lucienne, Ouermi and Yago-Wienne, Fanny and Touré, Djeinam and Dimithé, Georges and Khassanov, Regina and Sidibé, Souleymane and Somé, Noel Pouorinibé and Zhong, Lina and Chen, Cindi and Yu, Danny and Liu, YuHeng and Abraham, Thomas and Peterson, Brittany and Hinterwirth, Armin and Arnold, Benjamin F and O'Brien, Kieran and Oldenburg, Catherine E and Lebas, Elodie and Lietman, Thomas M and Doan, Thuy},
title = {Effect of Biannual Azithromycin Distribution to Infants on Community Gut Resistome and Microbiome: A Cluster-Randomized, Controlled Trial},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.25-0238}
}
EUVIMED